FDA restricts J&J's COVID-19 vaccine due to blood clot risk | AP News

FDA restricts J&J's COVID-19 vaccine due to blood clot risk | AP News: WASHINGTON (AP) — U.S. regulators on Thursday strictly limited who can receive Johnson & Johnson’s COVID-19 vaccine due to the ongoing risk of rare but serious blood clots. The Food and Drug Administration said the shot should only be given to adults who cannot receive a different vaccine or specifically request J&J's vaccine.

Comments

Popular posts from this blog

The conflict in Gaza: a view from Israel - The Lancet

George F. Will - Skip the lecture on Israel's 'risks for peace'